Otsuka Holdings Co., Ltd. (OTSKY) Discusses 24-Month eGFR Results of Sibeprenlimab in IgA Nephropathy from Phase III VISIONARY Study Prepared Remarks Transcript
Otsuka Holdings Co., Ltd. (OTSKY) Q2 2026 Earnings Call Prepared Remarks Transcript
Mayne Pharma Group (OTCMKTS:MAYNF - Get Free Report) and Otsuka (OTCMKTS:OTSKY - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, analyst recommendations and institutional ownership. Analyst Recommendations This is a summary of recent
| Health Care Equipment & Supplies Industry | Healthcare Sector | Makoto Inoue CEO | OTC PINK Exchange | 689164101 CUSIP |
| JP Country | 37,758 Employees | 29 Jun 2026 Last Dividend | - Last Split | - IPO Date |
Otsuka Holdings Co., Ltd., founded in 1921 and based in Tokyo, Japan, operates globally, engaging in diversified businesses that primarily encompass pharmaceuticals, nutraceuticals, consumer products, and other sectors. Known for its extensive research and development efforts, the company holds a significant position in the pharmaceutical arena, focusing on a wide array of therapeutic areas including psychiatry, neurology, oncology, and more. Adding to its healthcare-centric portfolio, Otsuka extends its offerings into various consumer products and services, aiming to cater to a broader spectrum of consumer needs and healthcare solutions.
Otsuka Holdings’ expansive product and services range across several domains, highlighting its diversified approach towards healthcare and consumer well-being: